From: Impact of COPD and sarcopenia on all-cause and respiratory mortality in US adults: NHANES 1999–2018
Character | Crude model | Model 1 | Model 2 | Model 3 | ||||
---|---|---|---|---|---|---|---|---|
HR (95%CI) | P | HR (95%CI) | P | HR (95%CI) | P | HR (95%CI) | P | |
All-cause mortality | ||||||||
COPD-/SAR- | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) | ||||
COPD-/SAR+ | 3.48(3.12, 3.89) | < 0.0001 | 1.39(1.25, 1.55) | < 0.0001 | 1.34(1.21, 1.48) | < 0.0001 | 1.33(1.20, 1.48) | < 0.0001 |
COPD+/SAR- | 4.47(3.57, 5.60) | < 0.0001 | 2.27(1.81, 2.84) | < 0.0001 | 1.94(1.57, 2.38) | < 0.0001 | 1.51(1.21, 1.88) | < 0.001 |
COPD+/SAR+ | 9.28(6.33, 13.60) | < 0.0001 | 2.62(1.92, 3.57) | < 0.0001 | 2.24(1.64, 3.07) | < 0.0001 | 1.87(1.32, 2.66) | < 0.001 |
p for trend | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 | ||||
Respiratory mortality | ||||||||
COPD-/SAR- | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) | ||||
COPD-/SAR+ | 4.38(2.76, 6.95) | < 0.0001 | 1.39(0.86, 2.27) | 0.18 | 1.26(0.74, 2.13) | 0.39 | 1.82(0.91, 3.63) | 0.09 |
COPD+/SAR- | 33.61(21.68, 52.12) | < 0.0001 | 12.12(7.25, 20.25) | < 0.0001 | 9.54(5.66,16.08) | < 0.0001 | 5.16(2.96, 9.01) | < 0.0001 |
COPD+/SAR+ | 74.51(38.40, 144.57) | < 0.0001 | 12.37(6.36, 24.06) | < 0.0001 | 10.95(5.38,22.28) | < 0.0001 | 8.69(3.95, 19.14) | < 0.0001 |
p for trend | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 |